Advancing Laparoscopic Surgery Through Innovation

TransEnterix is a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery for patients, surgeons, and health care facilities.

Patient-Side Robotic Surgery

TransEnterix is developing the SurgiBot System to enhance laparoscopic surgery through robotic assistance, while allowing surgeon to remain patient-side, in the sterile field.

Enabling Flexible Laparoscopy

TransEnterix developed flexible, catheter-based instruments to transmit the dexterity of the surgeon's motions through articulating channels.

Advancing Laparoscopic Surgery Through Innovation

TransEnterix is currently developing a patient-side robotic system called the SurgiBot™ System. The system is designed to be controlled directly by the surgeon, with enhanced vision and robotic motion. SurgiBot System design incorporates deployment of flexible instruments and a high-definition 3D articulating scope through a single incision.

The SurgiBot™ System is currently in development and has not yet been cleared by the FDA for sale in the United States or by other regulatory authorities for sale outside the United States

Learn More

News

December 19, 2014
TransEnterix Completes Successful Pre-Clinical Robotic Surgical Procedures; Management Affirms FDA Timeline

Read More

February 24, 2015
TransEnterix, Inc. Reports Operating Results for the Fourth Quarter and Full Year 2014

Read More

February 27, 2015
CORRECTING and REPLACING TransEnterix, Inc. to present at the Raymond James & Associates’ 36th Annual Institutional Investors Conference

Read More

February 12, 2015
TransEnterix, Inc. to Present at the RBC Capital Markets’ 2015 Global Healthcare Conference

Read More

Investors

Resources

Fourth Quarter and Fiscal Year 2014 Financial and Operating Results Conference Call:

Listen to Webcast